Tulisokibart Clinical Trials

1 actively recruiting trial across 1 location

▼ -1 trial since June 2026

Also known as: MK-7240, PRA023

Pipeline

Phase 2: 1

Top Sponsors

Merck Sharp & Dohme LLC1

Indications

Psoriatic Arthritis1
Arthritis1

Sun City, Arizona1 trial

Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)

Arizona Arthritis & Rheumatology Associates, P.C. ( Site 5117)

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.